Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 Biomarker disease BEFREE AKI was determined using the latest definition by AKIN and RIFLE criteria. 30025391 2018
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 GeneticVariation disease BEFREE The incidence, risk factors, and clinical outcomes of acute kidney injury (staged using the RIFLE classification) associated with intravenous acyclovir administration. 30741619 2018
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 GeneticVariation disease BEFREE Acute kidney injury (AKI) during the first 7 days was evaluated based on the RIFLE criteria. 29118769 2017
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 Biomarker disease BEFREE The patients with AKI were also classified according to RIFLE as follows: Risk (8.2%), Injury (13.4%), Failure (13.2%), Loss of kidney function (1.3%), and End-stage kidney disease (0.8%). 30581789 2018
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 GeneticVariation disease BEFREE Acute kidney injury was defined as the risk, injury, and failure categories, as per the RIFLE (risk, injury, failure, loss, end-stage kidney disease) classification. 23499421 2013
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 Biomarker disease BEFREE Outcome measures were AKI (as defined by the Risk, Injury, Failure, Loss, and End-stage renal failure [RIFLE] criteria) and in-hospital death. 20671226 2010
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 Biomarker disease BEFREE Patients with AKI had a higher mortality that did not increase with RIFLE stage. 30827532 2019
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 Biomarker disease BEFREE Serum levels of sCrea (P < 0.001), IxS (P < 0.001) and pCS (P < 0.05) were higher in patients with AKI according to RIFLE classification at D0. 30604232 2019
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 GeneticVariation disease BEFREE We conducted a systematic literature search of studies on AKI according to RIFLE, AKIN, or KDIGO criteria in trauma patients admitted to the ICU (PROSPERO CRD42017060420). 30725141 2019
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 Biomarker disease BEFREE Outcomes included acute kidney injury (AKI) defined by RIFLE and changes in serum creatinine (sCr), eGFR, and chronic kidney disease (CKD) staging up to 5 years. 28285957 2017
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 Biomarker disease BEFREE A total of 119 children of INS (age: 2-18 years) fulfilling the pediatric RIFLE criteria for the diagnosis of AKI were enrolled and followed up for 3 months to determine the outcome. 28093933 2017
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 GeneticVariation disease BEFREE The incidence of acute kidney injury (AKI) was assessed using RIFLE criteria. 31268640 2019
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 GeneticVariation disease BEFREE Safety was assessed using incidence of acute kidney injury (AKI) based on RIFLE (risk, injury, failure, loss, end-stage renal disease) criteria. 27139010 2017
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 Biomarker disease BEFREE Primary endpoint was AKI following the creatinine based RIFLE classification. 29045467 2017
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 GeneticVariation disease BEFREE Multivariate analysis identified model for end-stage liver disease score of ≥26 (OR 16.0, p = 0.0012) and post-transplant acute kidney injury (RIFLE criteria I- or F-class; OR 4.87, p = 0.047) as independent risk factors for IFI. 29649828 2019
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 Biomarker disease BEFREE AKI was defined as a 1.5-fold increase in serum creatinine per RIFLE criteria. 29872606 2017
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 Biomarker disease BEFREE However, postoperative AKI (assessed by 2 criteria) occurred more frequently in group HES than in group NoHES (by KDIGO criteria: 10.7% vs. 3.6%; OR 3.43 [95% CI, 1.67-7.04]; P < .001 and by RIFLE criteria: 9.6% vs. 2%; OR 3.32 [95% CI, 1.34-8.24]; P = .01). 28471979 2017
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 Biomarker disease BEFREE In this study, the presence of AKI was found to be an independent risk factor in the development of in-hospital mortality according to all classification systems (RIFLE, AKIN, CK, and KDIGO) in critically traumatic patients followed in ICU, and the compatibility between RIFLE, AKIN, and KDIGO was the highest among the classification systems. 28717983 2018
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 Biomarker disease BEFREE The incidence of postoperative AKI was compared using the RIFLE classification system for acute kidney injury. 31772554 2019
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 GeneticVariation disease BEFREE Sepsis patients were divided into no AKI, mild AKI, and severe AKI groups according to RIFLE criteria. 29682165 2018
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 GeneticVariation disease BEFREE There has been considerable progress over the last decade in the standardization of the acute kidney injury (AKI) definition with the publication of the RIFLE, AKIN, KDIGO and ERBP classification criteria. 30523562 2019
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 Biomarker disease BEFREE With the validation of the recent classification systems, RIFLE in 2004 and KDIGO, in use today, our understanding of AKI has evolved. 31203299 2019
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 Biomarker disease BEFREE The adoption of diagnostic criteria for AKI (RIFLE, AKIN and KDIGO) has facilitated comparison of data reported by different centres, confirming that even mild AKI is associated with excess mortality. 27803367 2017
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 Biomarker disease BEFREE AKI was defined according to the RIFLE criteria and recorded up to the 7th postoperative day. 31080127 2019
Entrez Id: 90678
Gene Symbol: LRSAM1
LRSAM1
0.100 GeneticVariation disease BEFREE Analyses confirmed associations of both RRI thresholds with all consensus AKI definitions (0.74; KDIGO: p = 0.05, AKIN: p = 0.03, RIFLE: p = 0.03, 0.79; KDIGO: p = 0.002, AKIN: p = 0.001, RIFLE: p = 0.004). 31699495 2020